Follow-up study of acute hepatitis C
Autor: | Stanley W.K. Im, Mun H. Ng, W. W. Peng, D. Tan |
---|---|
Rok vydání: | 1994 |
Předmět: |
Adult
Male China medicine.medical_specialty Blood transfusion medicine.medical_treatment Hepatitis C virus Molecular Sequence Data Disease medicine.disease_cause Polymerase Chain Reaction Serology Immunoenzyme Techniques Medical microbiology Virology medicine Humans Hepatitis Antibodies Seroconversion Base Sequence biology Patient Selection virus diseases Alanine Transaminase General Medicine Middle Aged Hepatitis C digestive system diseases Acute Disease biology.protein RNA Viral Female Viral disease Antibody Biomarkers Follow-Up Studies |
Zdroj: | Archives of Virology. 138:71-84 |
ISSN: | 1432-8798 0304-8608 |
DOI: | 10.1007/bf01310039 |
Popis: | An extended follow-up study of hepatitis C virus (HVC) infection was conducted in Guangzhou and its nearby regions on patients hospitalized with acute hepatitis. Routine screening of blood donors for HCV was not yet instituted at the time of this study. HCV was found to be a common cause of the disease, and the infection had a close association with recent histories of blood transfusion. Sequential sera obtained from patients during hospitalization and after discharge were tested for the presence of HCV antibodies by the first and the second generation of commercial test kits, for levels of alanine aminotransferase (ALT), and for the presence of HCV-RNA. The development of HCV antibodies in some of the patients may be delayed for protracted period following clinical onset. HCV-RNA was only intermittently detectable both before and after seroconversion. Six of 33 patients studied showed seroreversion and 5 of them were accompanied by loss of HCV-RNA and serum ALT returned to normal levels. The disease persisted in 24 of 27 patients without seroreversion, accompanied by intermittent detection of HCV-RNA throughout the protracted course of the infection. Our results indicate that both EIA for detection of HCV antibodies and PCR for serum HCV-RNA should be used in combination for reliable diagnosis of HCV infection and screening of blood for transfusion. |
Databáze: | OpenAIRE |
Externí odkaz: |